4D Molecular Therapeutics (FDMT) Competitor Comparison
We are evaluating the key criteria listed to compare 4D Molecular Therapeutics (FDMT) against its competitors in the Biotechnology industry.
Market Capitalization
99 / 368Gross Profits
220 / 278Total Revenue
160 / 300EBITDA
200 / 337Free Cashflow
203 / 352Quick Ratio
35 / 357Earnings per Share
219 / 359Dividend yield
0 / 6Total Cash
104 / 358Performance 3 years
198 / 368Performance 5 years
233 / 368Performance 10 years
209 / 368Linearity 3 years
114 / 368Linearity 5 years
185 / 368Linearity 10 years
163 / 368Total Rank
359 / 368Dividend Rank
319 / 368Valuation Rank
323 / 368Piotroski Rank
329 / 368Muliplier Rank
245 / 368Muliplier Rank - FDMT ranking 245 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.